β-Hydroxybutyrate inhibits inflammasome activation to attenuate Alzheimer’s disease pathology

Alzheimer’s disease (AD) is a progressive, late-onset dementia with no effective treatment available. Recent studies suggest that AD pathology is driven by age-related changes in metabolism. Alterations in metabolism, such as placing patients on a ketogenic diet, can alter cognition by an unknown me...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Neuroinflammation
Egile Nagusiak: Shippy, Daniel C., Wilhelm, Connor, Viharkumar, Patel A., Raife, Thomas J., Ulland, Tyler K.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2020
Gaiak:
Short Report
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7507727/
https://ncbi.nlm.nih.gov/pubmed/32958021
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12974-020-01948-5
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak